Cargando…

Low dose aspirin and low-molecular-weight heparin in the treatment of pregnant Libyan women with recurrent miscarriage

BACKGROUND: Recurrent miscarriage is a major women’s health problem. Aspirin and heparin have been shown to have potentially beneficial effects on trophoblast implantation. However, few published data on this issue are available from developing countries. METHODS: An open clinical trial was conducte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elmahashi, Mohamed O, Elbareg, Aisha M, Essadi, Fathi M, Ashur, Bashur M, Adam, Ishag
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892062/ https://www.ncbi.nlm.nih.gov/pubmed/24405979 http://dx.doi.org/10.1186/1756-0500-7-23

Ejemplares similares

Aspirin and Low-Molecular Weight Heparin Combination Therapy Effectively Prevents Recurrent Miscarriage in Hyperhomocysteinemic Women
por: Chakraborty, Pratip, et al.
Publicado: (2013)

Low molecular weight heparin use in unexplained recurrent miscarriage
por: Yuksel, Halide, et al.
Publicado: (2014)

Combination of aspirin and heparin in unexplained recurrent miscarriages – “Empirical or evidence based”
por: Jain, Prakriti, et al.
Publicado: (2011)

Aspirin/low-molecular-weight-heparins/methylprednisolone: Lack of efficacy: case report
Publicado: (2022)

Immunological effects of anti-coagulant unfractionated heparin in pregnant Chinese women with cryptic recurrent miscarriages
por: Hong, Yanli, et al.
Publicado: (2020)

Maternal and perinatal outcomes of low-dose aspirin plus low-molecular-weight heparin therapy on antiphospholipid antibody-positive pregnant women with chronic hypertension
por: Long, Shangqin, et al.
Publicado: (2023)

ALIFE2 study: low-molecular-weight heparin for women with recurrent miscarriage and inherited thrombophilia - study protocol for a randomized controlled trial
por: de Jong, Paulien G, et al.
Publicado: (2015)

Maternal Thrombophilia and Recurrent Miscarriage – Is There Evidence That Heparin is Indicated as Prophylaxis against Recurrence?
por: Stefanski, Ana-Luisa, et al.
Publicado: (2018)

The role of prophylactic use of low molecular weight heparin or aspirin in thromboembolic events in primary membranous nephropathy
por: Zou, Peimei, et al.
Publicado: (2019)

Apoptotic activity in Libyan breast cancer
por: Boder, Jamela, et al.
Publicado: (2012)

Efficacy and safety of low-dose aspirin combined with low-molecular-weight heparin in treatment of preeclampsia: a meta-analysis and systematic review
por: Wu, Chunfeng, et al.
Publicado: (2021)

Low-molecular-weight heparin in addition to low-dose aspirin for preventing preeclampsia and its complications: A systematic review and meta-analysis
por: Zheng, Li, et al.
Publicado: (2022)

Effect of prednisone, aspirin, low molecular weight heparin and intravenous immunoglobulin on outcome of pregnancy in women with antiphospholipid syndrome
por: XIAO, JING, et al.
Publicado: (2013)

Comparison of the Efficacy and Safety of Aspirin and Low-Molecular-Weight Heparin in Patients With a Fracture: A Meta-Analysis
por: Nimerta, FNU, et al.
Publicado: (2023)

Unfractionated and low molecular weight heparin
por: Lima, Marcelo, et al.
Publicado: (2014)

Effects of low-dose aspirin and heparin on the pregnancy outcome in women with antiphospholipid syndrome
por: Baiazid, Latifa, et al.
Publicado: (2022)

Effect of heparin and low-molecular weight heparin on serum potassium and sodium levels
por: Bengalorkar, Girish M., et al.
Publicado: (2011)

Diagnosis delay in Libyan female breast cancer
por: Ermiah, Eramah, et al.
Publicado: (2012)

Subtelomeric Rearrangements in Patients with Recurrent Miscarriage
por: Hajlaoui, Amani, et al.
Publicado: (2018)

Low Molecular Weight Heparin Treatment in Pregnant Women with a Mechanical Heart Valve Prosthesis
por: Lee, Jae Hoon, et al.
Publicado: (2007)

Heparin/low molecular weight heparins: Thrombocytopenia: 7 case reports
Publicado: (2021)

Low-Molecular-Weight Heparin Versus Aspirin in Early Management of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
por: Xia, Hui, et al.
Publicado: (2022)

Arterial indications for the low molecular weight heparins
por: Ageno, Walter, et al.
Publicado: (2001)

The Safety and Efficacy of Low-Molecular-Weight Heparin in Pregnant Women With Rheumatic Heart Disease and Valves Replacement
por: Alghamdi, Najwa, et al.
Publicado: (2022)

Aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in orthopaedic trauma patients: A patient-centered randomized controlled trial
por: Haac, Bryce E., et al.
Publicado: (2020)

Comparison of Low-Molecular-Weight Heparins Prepared From Ovine Heparins With Enoxaparin
por: Chen, Jianle, et al.
Publicado: (2019)

Why differentiate low molecular weight heparins for venous thromboembolism?
por: Fareed, Jawed, et al.
Publicado: (2007)

Illness perceptions of Libyans with T2DM and their influence on medication adherence: a study in a diabetes center in Tripoli
por: Ashur, Sana Taher, et al.
Publicado: (2015)

Preoperative aspirin continuation versus replacement therapy with low molecular weight heparin before coronary surgery: effects on postoperative bleeding risk
por: Spadaccio, Cristiano, et al.
Publicado: (2015)

Corrigendum: Low-molecular-weight heparin versus aspirin in early management of acute ischemic stroke: A systematic review and meta-analysis
por: Xia, Hui, et al.
Publicado: (2022)

Effectiveness of aspirin compare with heparin plus aspirin in recurrent pregnancy loss treatment: A Quasi experimental study
Publicado: (2014)

Retrospective Analysis of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Women With Recurrent Spontaneous Abortion
por: Zhao, Long, et al.
Publicado: (2021)

Upregulated serum granulysin levels in women with antiphospholipid antibody‐associated recurrent miscarriage are downregulated by heparin treatment
por: Ichikawa, Tomoko, et al.
Publicado: (2022)

Rates of clinically apparent heparin-induced thrombocytopenia for unfractionated heparin vs. low molecular weight heparin in non-surgical patients are low and similar
por: Locke, Charles FS, et al.
Publicado: (2005)

Low-molecular-weight heparins in the treatment of venous thromboembolism
por: Ageno , Walter, et al.
Publicado: (2000)

The Effect of Low Molecular Weight Heparins on Fracture Healing
por: Kapetanakis, Stylianos, et al.
Publicado: (2015)

Low-molecular weight heparin infusion as anticoagulation for haemodialysis
por: Wong, Steve Siu-Man, et al.
Publicado: (2016)

COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis
por: Perna, Alessandra F., et al.
Publicado: (2020)

Management of intentional overdose of low-molecular-weight heparin
por: Lu, Clara, et al.
Publicado: (2022)

Dental Fluorosis and Its Associated Factors Amongst Libyan Schoolchildren
por: Arheiam, Arheiam, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e9bbn562evrsqmon50c4qvdhp1